DH ENCHANTMENT, INC. (ENMI) Financial Statements (2024 and earlier)
Company Profile
Business Address |
6228 DARTLE STREET LAS VEGAS, NV 89130 |
State of Incorp. | NV |
Fiscal Year End | March 31 |
Industry (SIC) | 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
9/30/2023 MRQ | 3/31/2023 | 12/31/2022 MRQ | 3/31/2022 | |||
---|---|---|---|---|---|---|
ASSETS | ||||||
Current Assets | ||||||
Cash, cash equivalents, and short-term investments | 13 | 36 | 111 | |||
Cash and cash equivalents | 13 | 36 | 111 | |||
Receivables | 0 | 0 | 6 | |||
Inventory, net of allowances, customer advances and progress billings | 2 | |||||
Inventory | 2 | |||||
Other undisclosed current assets | 4 | |||||
Total current assets: | 15 | 36 | 121 | |||
Noncurrent Assets | ||||||
TOTAL ASSETS: | 15 | 36 | 121 | |||
LIABILITIES AND EQUITY | ||||||
Liabilities | ||||||
Current Liabilities | ||||||
Accounts payable and accrued liabilities | 453 | 226 | ||||
Accrued liabilities | 453 | 226 | ||||
Due to related parties | ✕ | 212 | 64 | |||
Other undisclosed current liabilities | 384 | 591 | 188 | |||
Total current liabilities: | 837 | 803 | 479 | |||
Noncurrent Liabilities | ||||||
Liabilities, other than long-term debt | 77 | |||||
Due to related parties | ✕ | 77 | ||||
Total noncurrent liabilities: | 77 | |||||
Total liabilities: | 837 | 803 | 556 | |||
Equity | ||||||
Equity, attributable to parent, including: | (822) | (767) | (434) | |||
Common stock | 831 | 831 | 831 | |||
Accumulated other comprehensive income (loss) | (2) | (3) | 0 | |||
Accumulated deficit | (1,658) | (1,602) | (1,272) | |||
Other undisclosed equity, attributable to parent | 6 | 6 | 6 | |||
Total equity: | (822) | (767) | (434) | |||
TOTAL LIABILITIES AND EQUITY: | 15 | 36 | 121 |
Income Statement (P&L) ($ in thousands)
9/30/2023 TTM | 3/31/2023 | 12/31/2022 TTM | 3/31/2022 | ||
---|---|---|---|---|---|
Revenues | 15 | 14 | 549 | ||
Cost of revenue | (7) | (8) | (439) | ||
Gross profit: | 8 | 6 | 109 | ||
Operating expenses | (385) | (337) | (543) | ||
Operating loss: | (376) | (332) | (434) | ||
Nonoperating income (expense) | (10) | 2 | |||
Other nonoperating income (expense) | 9 | ||||
Interest and debt expense | (7) | (9) | |||
Other undisclosed loss from continuing operations before equity method investments, income taxes | |||||
Loss from continuing operations before equity method investments, income taxes: | (386) | (337) | (443) | ||
Loss from equity method investments | (19) | ||||
Other undisclosed income from continuing operations before income taxes | 3 | 0 | |||
Loss from continuing operations before income taxes: | (386) | (354) | (443) | ||
Income tax expense | (3) | ||||
Loss from continuing operations: | (386) | (357) | (443) | ||
Loss before gain (loss) on sale of properties: | ✕ | ✕ | (300) | (443) | |
Other undisclosed net income | 27 | ||||
Net loss available to common stockholders, diluted: | (386) | (330) | (443) |
Comprehensive Income ($ in thousands)
9/30/2023 TTM | 3/31/2023 | 12/31/2022 TTM | 3/31/2022 | ||
---|---|---|---|---|---|
Net loss: | (386) | (330) | (443) | ||
Comprehensive loss: | (386) | (330) | (443) | ||
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (2) | (3) | 0 | ||
Comprehensive loss, net of tax, attributable to parent: | (388) | (333) | (443) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.